Results 211 to 220 of about 696,003 (270)
Some of the next articles are maybe not open access.
Vaccine, 2018
BACKGROUND Monovalent rotavirus vaccine (RV1) was introduced in Tanzania in January 2013 under the Reach Every Child initiative, to be given at ages 6 and 10 weeks.
Adolfine Hokororo, Margaret M Cortese
exaly +2 more sources
BACKGROUND Monovalent rotavirus vaccine (RV1) was introduced in Tanzania in January 2013 under the Reach Every Child initiative, to be given at ages 6 and 10 weeks.
Adolfine Hokororo, Margaret M Cortese
exaly +2 more sources
Vaccine, 2021
BACKGROUND This study is the first clinical trial for a parenteral non-replicating rotavirus vaccine developed using virus-like particle (VLP) technology.
Natsuki Kurokawa +13 more
semanticscholar +1 more source
BACKGROUND This study is the first clinical trial for a parenteral non-replicating rotavirus vaccine developed using virus-like particle (VLP) technology.
Natsuki Kurokawa +13 more
semanticscholar +1 more source
Effect of rotavirus genetic diversity on vaccine impact
Reviews in Medical Virology, 2021Group A rotaviruses (RVAs) are the leading cause of gastroenteritis, causing 0.2 million deaths and several million hospitalisations globally each year. Four rotavirus vaccines (RotarixTM, RotaTeqTM, Rotavac® and ROTASIIL®) have been pre‐qualified by the
A. Sadiq +3 more
semanticscholar +1 more source
Current Opinion in Infectious Diseases, 2000
The past few years have seen important developments in understanding the epidemiological and virological characteristics of rotaviruses, and rapid progress has been made in rotavirus vaccine development, but further challenges remain before a vaccine is introduced into widespread use.
Maureen, Lynch +3 more
openaire +2 more sources
The past few years have seen important developments in understanding the epidemiological and virological characteristics of rotaviruses, and rapid progress has been made in rotavirus vaccine development, but further challenges remain before a vaccine is introduced into widespread use.
Maureen, Lynch +3 more
openaire +2 more sources
Current Opinion in Pediatrics, 1999
A rotavirus vaccine was recently licensed by the Food and Drug Administration and is likely to be recommended for use in all infants by both the Advisory Committee on Immunization Practices and the American Academy of Pediatrics. If used as recommended, the vaccine is likely to prevent much of the 500,000 physician visits, 50,000 hospitalizations, and ...
P A, Offit, H F, Clark
openaire +2 more sources
A rotavirus vaccine was recently licensed by the Food and Drug Administration and is likely to be recommended for use in all infants by both the Advisory Committee on Immunization Practices and the American Academy of Pediatrics. If used as recommended, the vaccine is likely to prevent much of the 500,000 physician visits, 50,000 hospitalizations, and ...
P A, Offit, H F, Clark
openaire +2 more sources
Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy
Vaccine, 2017Onwipa Rochanathimoke +2 more
exaly +2 more sources
Vaccine, 2019
BACKGROUND Lanzhou Lamb rotavirus (LLR) vaccine was licensed in China in 2000. It was the only vaccine available in private market before 2018. However, the data about the post-marketing effectiveness is very limited. To assess the vaccine effectiveness (
Jie Li +9 more
semanticscholar +1 more source
BACKGROUND Lanzhou Lamb rotavirus (LLR) vaccine was licensed in China in 2000. It was the only vaccine available in private market before 2018. However, the data about the post-marketing effectiveness is very limited. To assess the vaccine effectiveness (
Jie Li +9 more
semanticscholar +1 more source
Rotavirus and Rotavirus Vaccines
2006Two new rotavirus vaccines have recently been licensed that will provide the intervention needed to diminish the huge burden of rotavirus disease among all children. In many upper and middle income countries, these vaccines will soon be available for the routine immunization of children.
Roger I, Glass +5 more
openaire +2 more sources
Rotavirus vaccines – an update
Expert Opinion on Biological Therapy, 2003Rotavirus vaccines offer the best hope to reduce the toll of acute rotaviral gastroenteritis in both developed and developing countries. An association with intussusception (IS) led to the withdrawal of the first licensed rotavirus vaccine in the USA in 1999, forcing a re-evaluation of the safety profile of potentially lifesaving vaccines.
Carl D, Kirkwood, Jim, Buttery
openaire +2 more sources
Impact of rotavirus vaccines on rotavirus disease
Expert Review of Anti-infective Therapy, 2012Rotaviruses are the most common cause of acute gastroenteritis in young children worldwide. Both licensed rotavirus vaccines (Rotarix™ [RV1] and RotaTeq™ [RV5]) are effective and safe. Studies from countries that have included RV1 or RV5 in the national immunization programs have demonstrated their safety and sustained efficacy under real-life ...
Lepage, Philippe, Vergison, Anne
openaire +3 more sources